Search Login Register

Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) Summary

Description: Tumors or cancer of the NASOPHARYNX.

Also Known As: Cancer of the Nasopharynx; Nasopharynx Cancer; Nasopharynx Neoplasms; Neoplasms, Nasopharyngeal; Cancer, Nasopharyngeal Show All >>

Networked: 591 relevant articles (34 outcomes, 95 trials/studies) for this Disease

Key Drugs and Agents for Nasopharyngeal Neoplasms

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Cisplatin (Platino) : 3 outcomes 17 studies in 37 results : FDA 6 Generic
  2. Fluorouracil (Carac) : 1 outcome 5 studies in 11 results : FDA 33 Generic
  3. docetaxel (Taxotere) : 1 outcome 5 studies in 8 results : FDA 3
  4. DNA (Deoxyribonucleic Acid) : 1 outcome 3 studies in 24 results : IBA
  5. Nasopharyngeal carcinoma : 1 outcome 3 studies in 14 results : IBA
  6. Carbon Monoxide : 1 outcome 1 study in 4 results : IBA
  7. taxane : 1 outcome 1 study in 1 result : IBA
  8. Thymidine Kinase : 1 outcome in 3 results : IBA
  9. Cyclin-Dependent Kinase Inhibitor p16 : 1 outcome in 1 result : IBA
  10. Ganciclovir (Cytovene) : 1 outcome in 1 result : FDA 7 Generic
Show All >>

Diseases Related to Nasopharyngeal Neoplasms

  1. Neoplasms (Cancer)
  2. Laryngeal Neoplasms (Laryngeal Cancer)
  3. Stomatitis
  4. Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
  5. Pain (Aches)
Show All >>

Key Therapies for Nasopharyngeal Neoplasms

Efficacy Chart >>
  1. Radiotherapy : 14 outcomes 18 studies in 174 results
  2. Drug Therapy (Chemotherapy) : 13 outcomes 12 studies in 82 results
  3. Adjuvant Chemotherapy : 2 outcomes 4 studies in 13 results
  4. Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) : 1 outcome 8 studies in 32 results
  5. Brachytherapy : 1 outcome 2 studies in 16 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.